NCT/Study#
NCT06778863 /
CLSP-1025-101
A Phase 1 Dose Escalation and Expansion Study of CLSP-1025 in Adult Patients with Solid Tumors that harbor the TP53-R175H Mutation
DISEASE GROUP:
Advanced Solid Tumors
current phase:
Phase I
STUDY STATUS:
Enrolling
Location:
Hackensack, NJ
For More information:
